In our study, although not significant, we observed a trend towards an increased frequency of active CD4+ Tfh cells in the blood, while quiescent CD4+ Tfh cells were not significantly altered in RA and RA-risk individuals when compared with HCs. This evidence concerns the gene CD4 and rheumatoid arthritis.